Goal: The current research project is focused on applying a novel synthetic epigenetic tool (Epi-CRISPRs) for straightforward, one-step pancreatic alpha to beta cell transdifferentiation by targeted DNA methylation and suppression of genes essential for maintaining pancreatic cell identity (homeobox genes Arx and Pax4).
The obtained results will be valuable for later Epi-CRISPRs use in mouse in vivo models of diabetes and eventually as a future therapy for diabetes attenuation in humans.
Period: 2015-2016
Phone: +381 11 20 78 300
Fax: +381 11 27 61 433
Email: ibiss@ibiss.bg.ac.rs
Bulevar despota Stefana 142
11108 Belgrade
Serbia
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.